Sky enthusiasts gear up to watch eclipse of super blue blood moon

TNN
January 31, 2018

New Delhi, Jan 31: Sky lovers are excited for the extraterrestrial triple treat to be witnessed in the sky today.

A super blue blood moon will be eclipsed on Wednesday from 6 PM to 9:30 PM at various locations across the country.

Sky enthusiasts have taken out their telescopes and booked a cosy place on their terrace or garden to watch the celestial spectacle.

If you want to see the whole event unfold, you should be away from tall buildings, bright lights, trees, things like that. You should have a clear view of the skies.

Lunar eclipse can be watched with naked eyes unlike solar eclipse.

This total lunar eclipse is special for three reasons: It's the third in a series of "supermoons" when the Moon will be just a day past perigee which is the closest point to Earth in it's orbit, making it appear very large and bright ; 2) It is about 14 percent bigger than usual and appearing 30 per cent brighter 3) It's the second full moon of the month, commonly known as a "blue moon". A supermoon is a particularly close full or new moon

While the Moon is in the Earth's shadow it will take on a reddish tint, known as a "blood moon."

There hasn't been a triple lineup like this since 1982, and the next won't occur until 2037.

As far as India is concerned, in 1982 on December 30, there was a lunar eclipse. Also it was second full moon of December 1982. i.e. Lunar Eclipse on Blue Moon in India occurred in 1982, said Sri N Raghunandan Kumar, Director & Founder Secretary of Planetary Society of India, Hyderabad.

The moon will rise in Delhi at 5:53:48 PM, while the partial eclipse will begin at 5:21:00 PM ( when the moon will be below horizon).The

total eclipse phase will begin at 6:21:47 PM and end at 7:37:51 PM.

The maximum eclipse will at 6:59:51 PM.

Places in north eastern states like Agartala, Aizawl, Cooch Bihar, Darjeeling, Dibrugarh, Gangtok, Guwahati, Imphal, Itanagar, Kohima, Kolkatta, Murshidabad, Shillong, Silchar, Silguri and Port Blair will appreciate all visible phases of the lunar eclipse.

The last time a lunar eclipse was visible in India occurred on August 7, 2017 which, however, was partial lunar eclipse.

And, the last time the "Blue Moon" occurred was in 2015 i.e. in July (2nd July 2015 & 31st July).

This year is astronomically very interesting as after 20 years we will have two Blue Moons in a calendar year i.e. January ( 2nd Jan & 31 Jan) 2018 and March (1st March and 31st March) 2018.

While amateur skywatchers catch the show, scientists across the world will watch the dramatic impact of the eclipse on the moon's surface— its temperature will drop as it passes into shadow.

SPACE India, an NGO which works to promote scientific temperament among children, will conduct an observation with telescopes at India Gate to promote public outreach on the night of January 31 from 6:00 to 8:30 PM. Educators will provide views of the Eclipsed Moon and elucidate the phases to people.

The NGO will also dispel myths about the chandra grahan among people.

Across the world this eclipse will be visible in the region covering North America except eastern part, Oceania, Russia, Asia, Middle East, northern Scandanavia and eastern Europe.

Comments

Hi, i think that i saw you visited my web site thus i came to
“return the favor”.I am attempting to find things to
enhance my site!I suppose its ok to use a few of your ideas!!

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 12,2020

Bengaluru, Mar 12: Imarti Devi, who recently resigned as Congress MLA from Madhya Pradesh, on Wednesday said that she was happy with Jyotiraditya Scindia's decision to join the BJP.

Imarti said: "All 22 MLAs are here (in Bengaluru) on their own. We're happy that Scindiaji has taken this decision. I'll always stay with him even if I had to jump in a well."

"When we were in the Congress, Kamal Nathji never heard us," she said.

Another rebel leader and former minister Mahendra Singh Sisodia said: "Betrayal is not done by Jyotiraditya Scindia. Instead, betrayal was done by the Congress and Kamal Nathji."

"Congress betrayed the people of Madhya Pradesh. We are with Jyotiraditya Scindia," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 29,2020

New Delhi, Jun 29: The Supreme Court on Monday asked the Central government to find out the facts related to blacklisting and canceling of visas of foreign nationals who attended the congregation of Tablighi Jamaat in Nizamuddin area here.

A three-judge bench headed by Justice AM Khanwilkar and also comprising Justices Dinesh Maheshwari and Sanjiv Khanna asked the Centre to find out the facts related to the matter and fixed it for further hearing on July 2.

The apex court asked Solicitor General Tushar Mehta "if visas of these foreigners are canceled, then why are they still in India?"

"You (Centre) can deport them. If visas are not canceled, then, it is a different situation," the court said. The top court was hearing a number of petitions challenging blacklisting and cancellation of visas filed by few foreigners.

Mehta sought more time to file a reply on the matter, after which the court posted the matter for further hearing on July 2.

The petitions, filed by the foreign nationals from 35 countries, have sought directions to the Ministry of Home Affairs (MHA) to remove their names from the blacklist, reinstate their visas and facilitate their return to their respective countries.

The petitions sought to declare the decision of the MHA of blacklisting the foreign nationals who attended the Tablighi Jamaat congregation as "arbitrary".

"Unilateral blacklisting of 960 foreigners by the Home Ministry vide press release dated April 2, 2020, and the subsequent blacklisting of around 2500 foreigners as reported on June 4, 2020, is in violation of Article 21. Therefore, it is void and unconstitutional as the petitioners have neither been provided any hearing nor notice or intimation in this regard," the plea said.

One of the petitioners named Fareedah Cheema, a Thai national in the seventh month of her pregnancy, said she was quarantined in March, like other foreign nationals but was released from quarantine only in late May and is still at a facility under restricted movements, without the avenue to go back to her home nation and experience the birth of her child with security and dignity, with her loved ones.

These foreign nationals presently in India were blacklisted for a period of 10 years from traveling to India for their alleged involvement in Tablighi Jamaat activities.

The Home Ministry had said that foreign Tablighi Jamaat members, who were staying in India in violation of visa rules during the nationwide lockdown implemented to combat the COVID-19 spread, have been blacklisted.
A large congregation organised by Tablighi Jamaat in the national capital in March had emerged as a major COVID-19 hotspot in the country.

The government had said the decision of banning the foreign Tablighi Jamaat members was taken after details of foreigners found illegally living in mosques and religious places emerged from various states across the country.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.